-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Adial Pharmaceuticals Signs An Exclusive Ad04 Collaboration Framework With Molteni Farmaceutici For Europe Which Anticipates Nearly $60 Million In Potential Royalties And Milestones Upon Execution Of A Definitive Agreement

Reuters·03/03/2026 13:18:48

Please log in to view news